Colchicine Dosing and Administration Guidelines

Introduction to Colchicine Therapy

The American College of Rheumatology recommends colchicine dosing for gout prophylaxis at 0.6 mg once or twice daily, continued for at least 6 months or 3 months after achieving target uric acid without tophi 8

Colchicine elimination half-life can increase up to sevenfold in patients with liver cirrhosis, from 9-16 hours to potentially >100 hours 1
Maximum recommended doses are 3 mg daily in adults and 2 mg daily in children, but these must be reduced substantially in hepatic impairment 1

Colchicine-induced gastrointestinal symptoms, such as diarrhea, nausea, and abdominal cramping, are the most common adverse effects and represent dose-limiting toxicity 2, 1
If GI symptoms occur, reduce the colchicine dose rather than discontinuing entirely when possible 2, 1

For acute gout treatment, the recommended dose is 1.2 mg at first symptom onset, followed by 0.6 mg one hour later, only if started within 36 hours of symptom onset 5
For gout prophylaxis, the recommended dose is 0.6 mg once or twice daily, continued for at least 6 months or 3 months after achieving target uric acid without tophi 8

The recommended dose for FMF maintenance in adults is 1.0-1.5 mg daily, titrated up to maximum 3 mg daily if needed 3, 4, 2
The recommended dose for FMF maintenance in children is ≤0.5 mg daily for <5 years, 0.5-1.0 mg daily for 5-10 years, and 1.0-1.5 mg daily for >10 years 3, 4

Never use the obsolete high-dose regimen for acute gout, as it causes severe diarrhea with no additional benefit 5, 7
Never ignore the 36-hour window for acute gout treatment effectiveness, as colchicine loses efficacy rapidly beyond this timeframe 5, 6, 7
Always calculate creatinine clearance before prescribing, especially in elderly patients who may have normal serum creatinine but reduced clearance 5
Monitor for neuromuscular toxicity and myopathy, especially when co-prescribed with statins in patients with renal impairment 7
Intravenous colchicine is discouraged and has absolute contraindications, including combined renal/hepatic disease, CrCl <10 mL/min, and extrahepatic biliary obstruction 4